EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Cardiac Damage in Degenerative Mitral Regurgitation Treated With Transcatheter Mitral Edge-to-Edge Repair

Atsushi Sugiura iD, Masanori Yamamoto, Mike Saji iD, Masahiko Asami iD, Yusuke Enta iD, Masaki Nakashima iD, Shinichi Shirai iD, Masaki Izumo iD, Shingo Mizuno, Yusuke Watanabe iD, Makoto Amaki, Kazuhisa Kodama und 14 weitere

Circulation: Cardiovascular Interventions · 2024

DOI: 10.1161/circinterventions.123.013794 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2024. Verfasst von Atsushi Sugiura und 25 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center Bonn, Department of Internal Medicine II, University Hospital Bonn, Germany (A.S., G.N.). Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Mitral Valve, Registries, Cardiac Catheterization. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The extent of cardiac damage and its association with clinical outcomes in patients undergoing transcatheter edge-to-edge repair (TEER) for degenerative mitral regurgitation remains unclear. This study was aimed to investigate cardiac damage in patients with degenerative mitral regurgitation treated with TEER and its association with outcomes. METHODS: We analyzed patients with degenerative mitral regurgitation treated with TEER in the Optimized Catheter Valvular Intervention-Mitral registry, which is a prospective, multicenter observational data collection in Japan. The study subjects were classified according to the extent of cardiac damage at baseline: no extravalvular cardiac damage (stage 0), mild left ventricular or left atrial damage (stage 1), moderate left ventricular or left atrial damage (stage 2), or right heart damage (stage 3). Two-year mortality after TEER was compared using Kaplan-Meier analysis. RESULTS: Out of 579 study participants, 8 (1.4%) were classified as stage 0, 76 (13.1%) as stage 1, 319 (55.1%) as stage 2, and 176 (30.4%) as stage 3. Two-year survival was 100% in stage 0, 89.5% in stage 1, 78.9% in stage 2, and 75.3% in stage 3 ( P =0.013). Compared with stage 0 to 1, stage 2 (hazard ratio, 3.34 [95% CI, 1.03–10.81]; P =0.044) and stage 3 (hazard ratio, 4.51 [95% CI, 1.37–14.85]; P =0.013) were associated with increased risk of 2-year mortality after TEER. Significant reductions in heart failure rehospitalization rate and New York Heart Association functional scale were observed following TEER (both, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyMitral ValveRegistriesCardiac CatheterizationHeart Valve Prosthesis ImplantationHumansMaleFemaleAgedJapanTreatment OutcomeTime FactorsProspective StudiesRisk FactorsAged, 80 and overRisk AssessmentRecovery of FunctionHeart Injuries

Stichwörter der Autor:innen

cardiac damagedegenerative mitral regurgitationheart failurerisk stratificationtranscatheter edge-to-edge repair

Autor:innen und Institutionen

  • Heart Center Bonn, Department of Internal Medicine II, University Hospital Bonn, Germany (A.S., G.N.).
  • Department of Cardiology, Toyohashi Heart Center, Japan (M. Yamamoto, Y.A.).
  • Department of Cardiology, Nagoya Heart Center, Japan (M. Yamamoto, Y.A.).
  • Department of Cardiology, Gifu Heart Center, Japan (M. Yamamoto).
  • Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan (M.S.).
  • Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine, Tokyo, Japan (M.S.).

ORCID-Profile: Atsushi Sugiura, Mike Saji, Masahiko Asami, Yusuke Enta, Masaki Nakashima, Shinichi Shirai, Masaki Izumo, Yusuke Watanabe, Junichi Yamaguchi, Yohei Ohno, Hiroshi Ueno, Kazuki Mizutani, Toshiaki Otsuka, Kentaro Hayashida

Zitieren

APA

Sugiura, A., Yamamoto, M., Saji, M., Asami, M., Enta, Y., Nakashima, M., Shirai, S., Izumo, M., Mizuno, S., Watanabe, Y., Amaki, M., Kodama, K., Yamaguchi, J., Nakajima, Y., Naganuma, T., Bota, H., Ohno, Y., Yamawaki, M., Ueno, H., …, & OCEAN-Mitral Investigators (2024). Cardiac Damage in Degenerative Mitral Regurgitation Treated With Transcatheter Mitral Edge-to-Edge Repair. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.123.013794

Vancouver

Sugiura A, Yamamoto M, Saji M, Asami M, Enta Y, Nakashima M, et al. Cardiac Damage in Degenerative Mitral Regurgitation Treated With Transcatheter Mitral Edge-to-Edge Repair. Circulation: Cardiovascular Interventions. 2024. doi:10.1161/circinterventions.123.013794

BibTeX
@article{Sugiura2024,
  author = {Sugiura, Atsushi and Yamamoto, Masanori and Saji, Mike and Asami, Masahiko and Enta, Yusuke and Nakashima, Masaki and Shirai, Shinichi and Izumo, Masaki and Mizuno, Shingo and Watanabe, Yusuke and Amaki, Makoto and Kodama, Kazuhisa and Yamaguchi, Junichi and Nakajima, Yoshifumi and Naganuma, Toru and Bota, Hiroki and Ohno, Yohei and Yamawaki, Masahiro and Ueno, Hiroshi and Mizutani, Kazuki and Adachi, Yuya and Otsuka, Toshiaki and Kubo, Shunsuke and Nickenig, Georg and Hayashida, Kentaro and OCEAN-Mitral Investigators, OCEAN-Mitral Investigators},
  title = {Cardiac Damage in Degenerative Mitral Regurgitation Treated With Transcatheter Mitral Edge-to-Edge Repair},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2024},
  doi = {10.1161/circinterventions.123.013794}
}
Kostenlos starten →